Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjeerd J Postma

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Drugs|July 31, 2003
Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal managementCarla C P Verstappen, Jan J Heimans, Klaas Hoekman, et al.
BMC Musculoskeletal Disorders|August 8, 2014
Parsonage-Turner syndrome following post-exposure prophylaxisDuncan P Fransz, Casper P Schönhuth, Tjeerd J Postma, et al.
Anticancer Research|August 28, 2004
Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigationCarla C P Verstappen, Tjeerd J Postma, Albert A Geldof, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 27, 2012
[Reversible neurological deficit years after high grade glioma--the SMART syndrome]Fonnet E Bleeker, Joseph C J Bot, Hanneke E Ronner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 30, 2005
Thallium-201 SPECT: the optimal prediction of response in glioma therapyMaaike J Vos, Johannes Berkhof, Tjeerd J Postma, et al.
The Oncologist|March 14, 2015
Platinum-induced neurotoxicity and preventive strategies: past, present, and futureAbolfazl Avan, Tjeerd J Postma, Cecilia Ceresa, et al.
Nuclear Medicine Communications|April 27, 2007
Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent gliomaMaaike J Vos, Ban N Tony, Otto S Hoekstra, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 26, 2015
Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility studyJohan A F Koekkoek, Tjeerd J Postma, Jan J Heimans, et al.
Nuclear Medicine Communications|December 18, 2004
Interobserver variability in the semi-quantitative assessment of 201Tl SPECT in cerebral gliomasBan Tony, Maaike J Vos, Johannes Berkhof, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 22, 2017
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)Jacobien M Kieffer, Tjeerd J Postma, Lonneke van de Poll-Franse, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Drugs|July 31, 2003
Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal managementCarla C P Verstappen, Jan J Heimans, Klaas Hoekman, et al.
BMC Musculoskeletal Disorders|August 8, 2014
Parsonage-Turner syndrome following post-exposure prophylaxisDuncan P Fransz, Casper P Schönhuth, Tjeerd J Postma, et al.
Anticancer Research|August 28, 2004
Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigationCarla C P Verstappen, Tjeerd J Postma, Albert A Geldof, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 27, 2012
[Reversible neurological deficit years after high grade glioma--the SMART syndrome]Fonnet E Bleeker, Joseph C J Bot, Hanneke E Ronner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 30, 2005
Thallium-201 SPECT: the optimal prediction of response in glioma therapyMaaike J Vos, Johannes Berkhof, Tjeerd J Postma, et al.
The Oncologist|March 14, 2015
Platinum-induced neurotoxicity and preventive strategies: past, present, and futureAbolfazl Avan, Tjeerd J Postma, Cecilia Ceresa, et al.
Nuclear Medicine Communications|April 27, 2007
Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent gliomaMaaike J Vos, Ban N Tony, Otto S Hoekstra, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 26, 2015
Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility studyJohan A F Koekkoek, Tjeerd J Postma, Jan J Heimans, et al.
Nuclear Medicine Communications|December 18, 2004
Interobserver variability in the semi-quantitative assessment of 201Tl SPECT in cerebral gliomasBan Tony, Maaike J Vos, Johannes Berkhof, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 22, 2017
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)Jacobien M Kieffer, Tjeerd J Postma, Lonneke van de Poll-Franse, et al.
Pageof 5